T1	Date 13 17	2012
T2	LIVB 433 442	pacientes
#1	AnnotatorNotes T2	C0030705; Patients; Patient or Disabled Group
T3	Spec_cue 468 474	riesgo
T5	Duration 616 632	el primeros días
T6	ANAT 787 794	injerto
#2	AnnotatorNotes T6	C0332835; Transplanted tissue; Tissue
T7	Duration 929 936	6 meses
T8	Neg_cue 1094 1102	negativa
T10	Duration 1199 1206	6 meses
T11	PROC 46 55	Protocolo
#3	AnnotatorNotes T11	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T12	PROC 59 70	seguimiento
#4	AnnotatorNotes T12	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T13	PROC 95 123	estudio fase II, doble ciego
T14	PROC 144 274	Estudio de fase II, multicéntrico, aleatorizado, doble ciego, controlado con placebo, de grupos paralelos, adaptativo y secuencial
T15	PROC 295 341	evaluar la seguridad, tolerabilidad y eficacia
T16	CHEM 357 389	anticuerpo monoclonal humanizado
#5	AnnotatorNotes T16	C2985546; Antibodies, Monoclonal, Humanized; Amino Acid, Peptide, or Protein · Immunologic Factor
T17	CHEM 345 352	OPN-305
#6	AnnotatorNotes T17	C3712029; OPN-305; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T18	DISO 486 519	retraso en la función del injerto
T19	PROC 447 463	trasplante renal
#7	AnnotatorNotes T19	C0022671; Kidney Transplantation; Therapeutic or Preventive Procedure
T20	PROC 545 555	Prevención
#8	AnnotatorNotes T20	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T21	DISO 562 584	lesión por reperfusión
#9	AnnotatorNotes T21	C0035126; Reperfusion Injury; Injury or Poisoning | C0349419; Ischemic reperfusion injury; Injury or Poisoning
T22	DISO 586 598	daño tisular
T23	PROC 637 647	trasplante
#10	AnnotatorNotes T23	C0040732; Transplantation; Therapeutic or Preventive Procedure
T24	ANAT 702 707	riñón
#11	AnnotatorNotes T24	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T25	PROC 708 720	trasplantado
#12	AnnotatorNotes T25	C0040732; Transplantation; Therapeutic or Preventive Procedure
T26	PROC 748 758	Prevención
#13	AnnotatorNotes T26	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T27	ANAT 811 816	renal
#14	AnnotatorNotes T27	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T28	PROC 817 827	trasplante
#15	AnnotatorNotes T28	C0040732; Transplantation; Therapeutic or Preventive Procedure
T29	PROC 992 1028	consentimiento informado por escrito
#16	AnnotatorNotes T29	C0811741; Obtain informed written consent; Health Care Activity
T30	PROC 943 960	ensayo de fase II
T31	PROC 1037 1046	protocolo
#17	AnnotatorNotes T31	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T32	PROC 1050 1061	seguimiento
#18	AnnotatorNotes T32	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T33	PROC 1112 1148	consentimiento informado por escrito
#19	AnnotatorNotes T33	C0811741; Obtain informed written consent; Health Care Activity
T34	CHEM 405 428	receptor de tipo Toll 2
#20	AnnotatorNotes T34	C0754728; Toll-Like Receptor 2; Amino Acid, Peptide, or Protein · Receptor
T35	ANAT 458 463	renal
#21	AnnotatorNotes T35	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T36	ANAT 512 519	injerto
#22	AnnotatorNotes T36	C0332835; Transplanted tissue; Tissue
T37	ANAT 591 598	tisular
#23	AnnotatorNotes T37	C0040300; Body tissue; Tissue | C1284837; Entire body tissue; Tissue
T38	PROC 1240 1281	estudio de investigación intervencionista
T39	DISO 765 794	función retardada del injerto
#24	AnnotatorNotes T39	C1566590; Delayed Graft Function; Pathologic Function
T40	DISO 796 799	DGF
#25	AnnotatorNotes T40	C1566590; Delayed Graft Function; Pathologic Function
T4	PROC 884 895	doble ciego
#26	AnnotatorNotes T4	C0013072; Double-Blind Method; Research Activity
T9	PROC 908 914	visita
#27	AnnotatorNotes T9	C1512346; Patient Visit; Health Care Activity
T41	PROC 1186 1192	visita
#28	AnnotatorNotes T41	C1512346; Patient Visit; Health Care Activity
T42	Quantifier_or_Qualifier 1193 1198	final
A1	Assertion T18 Speculated
A2	Assertion T33 Negated
A3	Status T4 History_of
A4	Status T30 History_of
#30	AnnotatorNotes T13	C0282460; Phase 2 Clinical Trials; Research Activity + C0013072; Double-Blind Method; Research Activity
#31	AnnotatorNotes T15	C0511730; Identify product efficacy and safety issues; Health Care Activity + C3274448; Tolerability Study; Research Activity
#32	AnnotatorNotes T18	C1566590; Delayed Graft Function; Pathologic Function 
#33	AnnotatorNotes T22	C0010957; Tissue damage; Injury or Poisoning
#34	AnnotatorNotes T30	C0282460; Phase 2 Clinical Trials; Research Activity
#35	AnnotatorNotes T38	C3274035; Interventional Study; Research Activity + C0681814; research study; Research Activity
#36	AnnotatorNotes T14	C0282460; Phase 2 Clinical Trials; Research Activity + C1096776; Multicenter Study; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product + C2826345; Parallel Study; Research Activity + C4553402; Group Sequential Design; Research Activity + C3274373; Adaptive Design; Research Activity
T43	Neg_cue 656 661	falta
T44	Observation 678 720	buen funcionamiento del riñón trasplantado
A5	Assertion T44 Negated
R1	Negation Arg1:T43 Arg2:T44	
#29	AnnotatorNotes T44	 C3532685; Normal renal function of transplanted kidney; Finding 
R2	Location_of Arg1:T24 Arg2:T44	
R3	Location_of Arg1:T24 Arg2:T25	
R4	Experiences Arg1:T2 Arg2:T17	
R5	Experiences Arg1:T2 Arg2:T16	
R6	Experiences Arg1:T2 Arg2:T19	
R7	Location_of Arg1:T35 Arg2:T19	
R8	Experiences Arg1:T2 Arg2:T45	
R9	Speculation Arg1:T3 Arg2:T18	
R10	Location_of Arg1:T36 Arg2:T18	
T45	Observation 468 485	riesgo elevado de
#37	AnnotatorNotes T45	C0332167; High risk of; Finding
R11	Before Arg1:T45 Arg2:T18	
R12	Before Arg1:T20 Arg2:T21	
R13	Before Arg1:T20 Arg2:T22	
R14	Location_of Arg1:T37 Arg2:T22	
R15	Location_of Arg1:T37 Arg2:T21	
R16	Overlap Arg1:T22 Arg2:T5	
R17	Overlap Arg1:T21 Arg2:T5	
R18	After Arg1:T22 Arg2:T23	
R19	After Arg1:T21 Arg2:T23	
R20	Overlap Arg1:T23 Arg2:T44	
R21	After Arg1:T21 Arg2:T25	
R22	After Arg1:T22 Arg2:T25	
R23	Location_of Arg1:T24 Arg2:T23	
R24	Overlap Arg1:T21 Arg2:T44	
R25	Overlap Arg1:T22 Arg2:T44	
R26	Before Arg1:T26 Arg2:T39	
R27	Before Arg1:T26 Arg2:T40	
R28	Location_of Arg1:T6 Arg2:T39	
R29	Location_of Arg1:T6 Arg2:T40	
R30	After Arg1:T39 Arg2:T28	
R31	After Arg1:T40 Arg2:T28	
R32	Location_of Arg1:T27 Arg2:T28	
T46	CONC 856 868	Finalización
#38	AnnotatorNotes T46	C1272693; Ended - status; Qualitative Concept
R33	After Arg1:T9 Arg2:T7	
R34	Before Arg1:T29 Arg2:T32	
R35	Before Arg1:T29 Arg2:T31	
R36	Negation Arg1:T8 Arg2:T33	
T47	Observation 1151 1159	Retirado
#39	AnnotatorNotes T47	C0422727; Patient withdrawn from trial; Finding (?)
R37	Before Arg1:T47 Arg2:T41	
R38	Has_Quantifier_or_Qualifier Arg1:T41 Arg2:T42	
R39	After Arg1:T41 Arg2:T10	
T48	Observation 1221 1281	se incluya en otro estudio de investigación intervencionista
R40	Experiences Arg1:T2 Arg2:T18	
#40	AnnotatorNotes T42	C3853528; Final; Temporal Concept
A6	Experiencer T2 Patient
A7	Status T48 Future
